Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daniel J. Chandra"'
Autor:
Edmund K. Waller, Bruce R. Blazar, Cynthia R. Giver, Daniel J. Chandra, Reema Panjwani, Jing-Xia Li, Christopher T. Petersen, Jian-Ming Li
The goal of allogeneic bone marrow transplantation (allo-BMT) is elimination of leukemia cells through the graft-versus-leukemia (GvL) activity of donor cells, while limiting graft-versus-host disease (GvHD). Immune checkpoint pathways regulate GvL a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e63cd4402fc747af3a73362903668f0
https://doi.org/10.1158/0008-5472.c.6508566.v1
https://doi.org/10.1158/0008-5472.c.6508566.v1
Autor:
Edmund K. Waller, Bruce R. Blazar, Cynthia R. Giver, Daniel J. Chandra, Reema Panjwani, Jing-Xia Li, Christopher T. Petersen, Jian-Ming Li
Supplementary Methods, Supplementary Figure S1, Transplantation of VIP-KO cells or treatment with VIPhyb did not increase GVHD; Supplementary Figure S2, VIPhyb did not suppress lymphoblastic leukemia growth in vitro; Supplementary Figure S3, VIPhyb-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b360ccfcfa7e77cfcbacb89a16e970e
https://doi.org/10.1158/0008-5472.22412955.v1
https://doi.org/10.1158/0008-5472.22412955.v1
Autor:
Daniel J. Chandra, Ross L. Levine, Caroline A. Lindemans, Noah F. Shroyer, Sean M. Devlin, S. Middendorp, Joris Bos, Margaret O'Connor, Alan M. Hanash, M. Kleppe, Shuichiro Takashima, Anastasiya Egorova, Paola Vinci, Chen Liu, Maria Laura Martin, Suze A. Jansen, Anna Mertelsmann, Jason Kuttiyara, Yuan-Hung Lo, Richard Kolesnick, Ya-Yuan Fu, Emily H. Cheng, Marco Calafiore
Publikováno v:
Science Immunology. 4
Despite the importance of intestinal stem cells (ISCs) for epithelial maintenance, there is limited understanding of how immune-mediated damage affects ISCs and their niche. We found that stem cell compartment injury is a shared feature of both allor
Autor:
Zachariah DeFilipp, Stefanie Sarantopoulos, W A C Harris, M Purcell, C Gleason, Edmund K. Waller, Daniel J. Chandra, J Wrammert
Publikováno v:
Bone Marrow Transplantation. 51:607-609
Monitoring the kinetics of B-cell recovery following rituximab may guide the management of steroid-refractory chronic GvHD
Publikováno v:
Journal of Thoracic Oncology. 14:S938
Autor:
Daniel J. Chandra, Edmund K. Waller, Reema Panjwani, Jian-Ming Li, Cynthia R. Giver, Christopher T. Petersen, Bruce R. Blazar, Jing Xia Li
Publikováno v:
Cancer research. 76(23)
The goal of allogeneic bone marrow transplantation (allo-BMT) is elimination of leukemia cells through the graft-versus-leukemia (GvL) activity of donor cells, while limiting graft-versus-host disease (GvHD). Immune checkpoint pathways regulate GvL a
Autor:
Joris Bos, Alan M. Hanash, Anna Mertelsmann, Shuichiro Takashima, Noah F. Shroyer, Yuan-Hung Lo, Anastasiya Egorova, Daniel J. Chandra, Marco Calafiore, Suze A. Jansen, Margaret O'Connor, Caroline A. Lindemans
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S68
Publikováno v:
The Journal of Immunology. 196:140.18-140.18
Chronic graft versus host disease (cGVHD) continues to be a major source of morbidity and mortality in allogeneic hematopoietic stem cell transplant (allo-HSCT) patients, and current therapies are limited by severe toxicity and immunosuppression. Num